Stock Price
111.32
Daily Change
-2.76 -2.42%
Monthly
-7.09%
Yearly
18.16%
Q2 Forecast
111.47

Novartis reported $1.99 in EPS Earnings Per Share for its fiscal quarter ending in March of 2026.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q1 Mar/2026 1.99 2.28 Apr/28
FY2025Q4 Dec/2025 2.03 1.98 Apr/02
FY2025Q3 Sep/2025 2.04 1.58 Oct/28
FY2025Q2 Jun/2025 2.42 1.97 Jul/17
FY2025Q1 Mar/2025 2.28 1.80 Apr/29




Eps Change Date
AbbVie USD 2.71 0.85 Dec/2025
Alcon AG USD 0.78 0.01 Dec/2025
Almirall EUR 0.07 0.03 Dec/2025
Amgen USD 5.29 0.35 Dec/2025
AstraZeneca USD 2.12 0.26 Dec/2025
Autolus Therapeutics Ltd USD -0.34 0.04 Dec/2025
Bayer EUR 0.62 0.05 Dec/2025
Biogen USD 1.99 2.82 Dec/2025
Bristol-Myers Squibb USD 1.26 0.37 Dec/2025
Eli Lilly USD 7.54 0.52 Dec/2025
Fresenius EUR 0.78 0.04 Dec/2025
Fresenius Medical Care EUR 1.44 0.34 Dec/2025
Galapagos EUR 11.89 12.3 Dec/2025
Genmab DKK 3.69 2.77 Dec/2025
Gilead Sciences USD 1.86 0.61 Dec/2025
GlaxoSmithKline GBP 0.26 0.29 Dec/2025
GRIFOLS EUR 0.25 0.04 Dec/2025
Hikma Pharmaceutical USD 0.65 0.12 Dec/2025
J&J USD 2.7 0.24 Mar/2026
Lonza CHF 6.07 1.92 Jun/2025
Merck EUR 1.88 0.44 Dec/2025
Merck USD 2.04 0.54 Dec/2025
Novartis USD 1.99 0.04 Mar/2026
Novartis USD 1.54 0.48 Dec/2025
Novo Nordisk DKK 6.04 1.54 Dec/2025
Orion EUR 0.66 1.19 Mar/2026
Pfizer USD 0.66 0.21 Dec/2025
Philips EUR 0.6 0.24 Dec/2025
Recordati EUR 0.73 0.06 Dec/2025
Regeneron Pharmaceuticals USD 11.44 0.39 Dec/2025
Roche Holding CHF 8.37 2.95 Dec/2025
Sanofi EUR 1.88 0.35 Mar/2026
UCB EUR 5.65 3.21 Dec/2025